miR-132 improves the cognitive function of rats with Alzheimer's disease by inhibiting the MAPK1 signal pathway.
In conclusion, miR-132 inhibited hippocampal iNOS expression and oxidative stress by inhibiting MAPK1expression to improve the cognitive function of rats with AD.
PMID: 33093897 [PubMed]
Source: Experimental and Therapeutic Medicine - Category: General Medicine Tags: Exp Ther Med Source Type: research
More News: Alzheimer's | Brain | General Medicine | Learning | Neurology | Study | Universities & Medical Training | Websites